Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: A cost-effectiveness analysis

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3 SUPPL., 2005, Pages 1274-1279

  Little, Sarah E ^a   Caughey, Aaron B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acyclovir; Antiviral therapy; Cost effectiveness analysis; Decision analysis; Neonatal herpes simplex virus infection

Indexed keywords

ACICLOVIR;

ANAMNESIS; CESAREAN SECTION; CHILD DEATH; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GENITAL HERPES; HEALTH CARE COST; HERPES SIMPLEX; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MONTE CARLO METHOD; NEWBORN DEATH; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY ADJUSTED LIFE YEAR; RECURRENT DISEASE; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY;

ACYCLOVIR; ADULT; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HERPES GENITALIS; HUMANS; MONTE CARLO METHOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 24644440998     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.05.042     Document Type: Conference Paper

References (25)

1. K.M. Gutierrez, M.S. Falkovitz Halpern, Y. Maldonado, and A.M. Arvin The epidemiology of neonatal herpes simplex virus infections in California 1985 to 1995 J Infect Dis 180 1999 199 202
2. R. Whitley Neonatal herpes simplex virus infection Curr Opin Infect Dis 7 2004 243 246
3. A.G. Randolph, E. Washington, and C.G. Prober Cesarean delivery for women presenting with genital herpes lesions JAMA 270 1993 77 82
4. Z.A. Brown, A. Wald, R.A. Morrow, S. Selke, J. Zeh, and L. Corey Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant JAMA 289 2003 203 209
5. J.S. Sheffield, L.M. Hollier, J.B. Hill, G.S. Stuart, and G.D. Wendel Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review Obstet Gynecol 102 2003 1396 1403
6. L. Braig, D. Luton, O. Sibony, C. Edlinger, C. Boissinot, and P. Blot Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding Eur J Obstet Gynecol Reprod Biol 96 2001 55 58
7. A.G. Randolph, R.M. Hartshorn, and A.E. Washington Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis Obstet Gynecol 88 1996 603 610
8. L.L. Scott, and J. Alexander Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in pregnancy Am J Perinat 15 1998 57 62
9. T. Masoaka, H. Shibata, I. Amaki, H. Takeo, K. Sakurai, and T. Ise [The clinical effects of a new antiviral 9-(2-hydroxyethoxymethyl) guanine (acyclovir) against herpes virus infections] Gan To Kagaku Ryoho 10 1983 944 952
10. National Center for Health Statistics. National Vital Statistics United States for 2003. Hyattsville, Md: Public Health Services; 2003.
11. D. Baker, Z. Brown, L.M. Hollier, G.D. Wendel Jr., L. Hulme, and D.A. Griffiths Cost-effectiveness of herpes simplex virus type 2 serological testing and antiviral therapy in pregnancy Am J Obstet Gynecol 191 2004 2074 2084
12. R.J. Lilford, H.A. van Coeverden de Groot, P.J. Moore, and P. Bingham The relative risks of caesarean section (intrapartum and elective) and vaginal delivery: a detailed analysis to exclude the effects of medical disorders and other acute pre-existing physiological disturbances BJOG 97 1990 883 892
13. L. Solomon, M.J. Cannon, M. Reyes, J.M. Graber, N.T. Wetherall, and W.C. Reeves Epidemiology of recurrent genital herpes simplex virus types 1 and 2 Sex Transm Infect 79 2003 456 459
14. D.J. Rouse, and J.S.A. Stringer An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes Am J Obstet Gynecol 183 2000 400 406
15. United States Department of Labor Bureau of Labor Statistics. Consumer Price Indices. Washington DC: United States Bureau of Labor Statistics; 2005.
16. R.V. Barnabas, H. Carabin, and G.P. Garnett The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis Sex Trans Infect 78 2002 425 429
17. N.J. Waitzman, P.S. Romano, and R.M. Scheffler Estimates of the economic costs of birth defects Inquiry 31 1994 188 205
18. D.J. Rouse, J. Owen, R.L. Goldenberg, and S.P. Cliver The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound JAMA 276 1996 1480 1486
19. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York
20. A. Angeja, A.B. Caughey, J. Vargas, R. Gomez, and A.E. Washington Chilean women's preferences regarding mode of delivery: Which do they prefer and why? Obstet Gynecol 103 2004 117S
21. M. Kuppermann, R.F. Nease, L.A. Learman, E. Gates, B. Blumberg, and A.E. Washington Procedure-related miscarriages and Down syndrome affected births: Implications for prenatal testing based on women's preferences Obstet Gynecol 96 2000 511 516
22. Strauss D, Shavelle R, Day S. Life Expectancy Project. Available from: http://www.lifeexpectancy.com/cp.shtml. Accessed April 25, 2005.
23. S. Saigal, B.L. Stoskopf, D. Feeny, W. Furlong, E. Burrows, and P.L. Rosenbaum Differences in preferences for neonatal outcome among health care professionals, parents and adolescents JAMA 281 1999 1991 1997
24. Z.A. Brown, S. Selke, J. Zeh, J. Kopelman, A. Maslow, and R.L. Ashley The acquisition of herpes simplex virus during pregnancy N Engl J Med 337 1997 509 515
25. K. Stone, R. Reiff-Eldridge, A.D. White, J.F. Cordero, Z. Brown, and E.R. Alexander Pregnancy outcome following systematic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999 Birth Defects Res Clin Mol Teratol 70 2004 201 207